Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » Week in Review

Week in Review


Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Recent Articles

  Week in Review: C-Bridge Raises $400 Million for Second China Healthcare Fund
  Week in Review: BGI Genomics Completes $81 Million Chi-Next IPO
  Week in Review: BeiGene Sets Record with $1.4 Billion Celgene Deal
  Week in Review: Sinovac's Privatization Offer Draws $459 Million Outside Bid
  Week in Review: BGI Genomics Plans $250 Million Shenzhen IPO
  Week in Review: IHH Building $1 Billion of China Hospitals; Seeks Deals for More
  Week in Review: WuXi Biologics Raises $511 Million in Hong Kong IPO
  Week in Review: Hong Kong's Cirina Merges with GRAIL for Early Stage Cancer Diagnostics
  Week in Review: China Life Science Venture Tie-up: WuXi and Frontline Merge
  Week in Review: Shanghai Pharma Considers $4 Billion Bid for Germany's Stada